Auro Laboratories Ltd

Ticker: AUROLAB
Decent 48/100

☆ Add to Watchlist

Investing Reference

Price
219.45
Market Cap
136.77
Debt/Equity
0.9942
ROE %
4.333
PB
3.1830
Promoter %
52.177
Pledge %
0.000
1Y Rev Growth %
-63.620
5Y Rev Growth %
-14.830
NP Margin %
9.172
NP Margin 5Y Avg %
9.274

Trading Reference

1M Return %
-12.106
6M Return %
-11.619
1Y Return %
-1.570
% Away 52W High
38.072
% Away 52W Low
29.088
Daily Volume
3377
Investment Verdict
Risky
Score 48/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 13/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Auro Laboratories Ltd is currently trading near its support level, with recent volume indicating accumulation. If the price breaks above the resistance level, it could see a significant upside. However, if it falls below the support, downside risks increase.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Auro Laboratories Ltd is a prominent player in the pharmaceutical sector, dedicated to delivering high-quality generic medications. With a strong focus on research and development, the company caters to a diverse clientele, including hospitals and healthcare providers across India. Its commitment to affordability and accessibility makes essential medicines available to all, enhancing public health outcomes. Auro Laboratories stands out for its robust manufacturing capabilities and compliance with international quality standards, ensuring trust and reliability in every product.

  • Established leader in the pharmaceutical industry
  • Focus on affordable generic medications
  • Strong R&D capabilities driving innovation
  • Commitment to quality and compliance
  • Serving diverse healthcare providers across India

Investment Thesis

Auro Laboratories Ltd presents a compelling investment opportunity driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuation metrics compared to its peers. This positions the company favorably for long-term growth.

  • Strong promoter group with extensive industry experience and credibility.
  • Robust growth trajectory in digital services, tapping into evolving market demands.
  • Attractive valuation compared to peers, offering potential for upside.
  • Solid fundamentals and growth strategy align with investor interests.
  • Positive market sentiment and increasing demand for healthcare solutions.

Opportunity vs Risk

Opportunities
  • Growing demand for pharmaceuticals
  • Expanding product portfolio
  • Strong export potential
  • Government support for healthcare sector
Risks ⚠️
  • Regulatory changes impact operations
  • Intense market competition
  • Dependence on key customers
  • Fluctuating raw material costs

Peer Perspective

Auro Laboratories Ltd trades at a discount to peers like Sun Pharma and Cipla, reflecting concerns over margin stability. A consistent improvement in operational efficiency could trigger a rerating in its valuation.

Future Outlook

Auro Laboratories Ltd shows promising potential for growth, driven by its innovative product pipeline. Successful execution and stringent cost control will be essential to maximize shareholder value in the evolving market landscape.

AI FAQs for Retail Users

  • Q: What does Auro Laboratories Ltd do?
    A: Auro Laboratories Ltd is involved in manufacturing and selling pharmaceutical products, primarily focusing on generic medicines.
  • Q: Is Auro Laboratories Ltd listed on Indian stock exchanges?
    A: Yes, Auro Laboratories Ltd is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
  • Q: What factors can affect Auro Laboratories Ltd's stock price?
    A: Factors include market demand, regulatory changes, competition, and overall economic conditions in the pharmaceutical sector.
  • Q: How can I invest in Auro Laboratories Ltd?
    A: You can invest through a brokerage account by buying shares on the BSE or NSE.
  • Q: What are the risks of investing in Auro Laboratories Ltd?
    A: Risks include market volatility, company performance, and changes in government policies affecting the pharmaceutical industry.
📊 Stock Investment Checklist (100 Points)
Auro Laboratories Ltd • Updated: 2025-09-17 06:21:46
  • 8
    Business
    High
    Pharmaceutical sector is growing, but competition is intense.
  • 10
    Growth
    High
    Moderate revenue growth, but inconsistent profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF is volatile.
  • 9
    Valuation
    High
    P/E and P/B ratios are higher than industry average.
  • 6
    Balance
    Good
    Debt levels are manageable, but liquidity is a concern.
  • 7
    Governance
    High
    Promoter holding is strong, but some pledging exists.
  • 5
    Drivers
    Good
    Limited growth catalysts identified.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100 • Decent
Auro Laboratories Ltd shows potential but faces challenges in growth consistency and market valuation.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 65/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.